Navigation Links
Dr. James Douglas Adds Human Growth Hormone (HGH) Therapy to IVF Protocols for Poor Responding Patients
Date:12/18/2012

Plano, Texas (PRWEB) December 18, 2012

As a reproductive endocrinologist, Dr. James Douglas specializes in helping infertile women have children. In some cases, patients do not respond well to fertility treatments, and may mistakenly believe that donor eggs are the only option. To help couples explore alternative therapies before moving to donor eggs, Dr. Douglas has begun utilizing human growth hormone (HGH) to give these patients additional choices.

“I understand the strong desire for a biological child,” explained Dr. Douglas. “We have seen success with HGH therapy in certain cases, and are now recommending it as a course of treatment for some of our poor responding patients.”

Typically, "poor responders" are patients that require increased dosing of gonadotropin therapy, have poor ovarian reserve testing and are over 35. Fertility specialists routinely see this type patients in their offices.

“Often, these women have tried in-vitro fertilization (IVF), and the cycles then failed to result in pregnancy, or were cancelled due to lack of response to medication,” Dr. Douglas said.

The benefits of HGH treatment coupled with ovarian stimulation were first reported 20 years ago. However, this treatment never gained widespread use despite studies touting the benefits.

“More studies are becoming available to support HGH therapy, and the fertility community is responding accordingly,” said Dr. Douglas.

With HGH therapy, patients take subcutaneous injections for six days during the stimulation stage of the IVF cycle. The HGH is thought to help with oocyte maturation, improving egg quality especially in older women.

HGH is also being studied for use in treatment of other medical conditions, such as multiple sclerosis, fibromyalgia, Crohn's disease and ulcerative colitis.

While cautiously optimistic, Dr Douglas sees HGH as a potential second chance for a biological child for some couples struggling with infertility

“We are excited to have another option that may allow our patients to have the babies they so desperately desire,” Dr. Douglas said.

About IVF Plano
For over 20 years, Dr. James Douglas and the team at IVF Plano fertility clinic have served the Dallas area, offering advanced diagnostic tools, the latest treatments for infertility and exceptional pregnancy rates. Dr. Douglas has helped thousands of patients in the Plano TX area achieve their goals of starting or expanding their families. For more information about the clinic, please visit http://www.ivfplano.com

Read the full story at http://www.prweb.com/releases/ivfplano/12/prweb10228871.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. James bond: A graphene/nanotube hybrid
2. Laureate Biopharma Names James D. Utterback to Board of Directors
3. Herbal Microscopy Book Receives American Botanical Councils James A. Duke Book Award
4. InspireMD Appoints Dr. James Barry to Its Board of Directors
5. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
6. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
7. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
8. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
9. Remixed brain waves reveal soundtrack of the human brain
10. Harvards Wyss Institute models a human disease in an organ-on-a-chip
11. Antibiotic contamination a threat to humans and the environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or ... pleased to announce that Biohaven has issued today the ... Connecticut (PRWEB) Dec 9, 2016 - Biohaven ... today that the U.S. Food and Drug Administration ("FDA") ... its drug candidate BHV-0223, an orally dissolving tablet being ...
(Date:12/8/2016)... PITTSBURGH , Dec. 8, 2016  The Board ... (PLSG), Western Pennsylvania,s only ... in leadership. In accordance with the succession plan developed ... several years, effective today, James (Jim) F. Jordan ... Executive Officer, succeeding John W. Manzetti , who ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Lajollacooks4u, San ... a banner year for team building events, new program offerings and company expansion. ... expanded earlier this year to include groups of over 30 people. Ever since, Lajollacooks4u ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... platforms, the business of innovation is taking over sports. On Thursday, December 15th ... explore how technology is disrupting the playing field at a Smart Talk session. ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):